Trending Articles
Trending Topics
Trending
SAP has signed a strategic agreement with German health giant Fresenius to develop a shared ecosystem for digital services.
The deal will see the pair work together to create a joint healthcare platform and the “future-oriented and AI-supported” services that will sit on top of it, according to SAP. The backbone for the new platform will be existing SAP products, including Business AI, Business Suite, Business Data Cloud and Business Technology Platform.
In addition, the two companies aim to build a platform that supports a sovereign European “integrated healthcare ecosystem”. The platform will work with existing hospital IT systems that are based on HL7 FHIR and other standards for healthcare data, including electronic medical records.
Fresenius and SAP will both invest a “mid three-digit million euro amount” into their European healthcare endeavours, SAP said. As well as spending on their own joint technology development, the pair will invest in digital healthcare startups.
Healthcare company Fresenius is headquartered in the German city of Bad Homburg vor der Höhe, with operations across Europe, Russia, India and North America.
The company is targeting three main business strands for this future growth: pharmaceuticals, medtech and healthcare services, including running hospitals and dialysis services. Its last set of quarterly results, for the third quarter of the 2025 financial year, saw the company earn nearly €5.5 billion.
The partnership with SAP follows a deal last month with HP Inc, which saw Fresenius subsidiary mAbxience sign up with the company to develop AI that can make the manufacture of biologics, including as monoclonal antibodies and biosimilars, more efficient.
The company has also been using AI in its medical facilities, including through its Scribe app, used in some of its facilities in Spain and Germany to transcribe and process conversations between doctors and patients – assisting with documentation and prescriptions, for example.
According to analysts Grand View Research, the global digital health market was worth round $290 billion in 2024. It expects the figure to reach nearly $950 billion by the end of the decade, driven in part by the rise in people living chronic conditions such as heart disease and diabetes, which require remote monitoring and management.
